Axcelis Technologies, Inc. (NASDAQ:ACLS) is a semiconductor equipment manufacturer specializing in ion implantation for chip fabrication. B. Riley maintained a Neutral rating on ACLS shares with a price target of $84 after the firm reported $213 million in revenue and $1.21 in earnings per share, beating analyst estimates. ACLS plans to merge with Veeco Instruments in a $4.4 billion deal. Veeco also operates in semiconductor equipment, producing etching, deposition, and ionization tools.

Read more at Yahoo Finance: B. Riley Keeps Neutral Rating On Axcelis Technologies (ACLS)’s Shares